Nasopen by is a Otc medication manufactured, distributed, or labeled by GM Pharmaceuticals, INC. Drug facts, warnings, and ingredients follow.
Nasopen PE
NDC: 58809-729-04
Tamper evident by foil seal under cap.
Do not use if foil seal is broken or missing.
Supplied in a tight, light-resistant container with a child-resistant cap.
Distributed by: GM Pharmaceuticals, Inc.
Arlington, TX 76015
Drug Facts
Do not exceed recommended dosage.
Adults and children 12 years of age and over: | 15 mL (1 TBSP) every 4 hours, not to exceed 90 mL (6 TBSP) in a 24 hour period. |
Children 6 to under 12 years of age: | 7.5 mL (1/2 TBSP) every 4 hours, not to exceed 45 mL (3 TBSP) in a 24 hour period. |
Children under 6 years of age: | Consult a doctor. |
NASOPEN
PE
phenylephrine hydrochloride, thonzylamine hydrochloride liquid |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - GM Pharmaceuticals, INC (793000860) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NASOPEN 85438905 4149998 Live/Registered |
GM Pharmaceuticals, Inc. 2011-10-04 |